West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$239.26 USD
0.00 (0.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $239.18 -0.08 (-0.03%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WST 239.26 0.00(0.00%)
Will WST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Other News for WST
Altria Among 6 Dividend Kings To Announce Annual Payout Increases In August
West Pharmaceutical: Q2 Earnings Suggest Recovery
Baron Asset Fund Q2 2025 Shareholder Letter
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financial Metrics and Competitive ...
Best Dividend Aristocrats For August 2025